Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Vaccine Adjuvants Market, by Region, 2020-2030 (USD Billion)
1.2.2. Vaccine Adjuvants Market, by Type,2020-2030 (USD Billion)
1.2.3. Vaccine Adjuvants Market, by Application , 2020-2030 (USD Billion)
1.2.4. Vaccine Adjuvants Market, by Administration, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Vaccine Adjuvants Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Vaccine Adjuvants Market Dynamics
3.1. Vaccine Adjuvants Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.1.3. Rising awareness towards immunization
3.1.1.4.
3.1.2. Market Challenges
3.1.2.1. High Cost of Vaccine Adjuvants
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Rising Healthcare Facilities
Chapter 4. Global Vaccine Adjuvants MarketIndustry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Vaccine Adjuvants Market, by Type
5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Type2020-2030 (USD Billion)
5.4. Vaccine Adjuvants Market, Sub Segment Analysis
5.4.1. Pathogen
5.4.2. Adjuvant emulsion
5.4.3. Particulate
5.4.4. Combination
5.4.5. Others
Chapter 6. Global Vaccine Adjuvants Market, by Application
6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Application , Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Vaccine Adjuvants Market, Sub Segment Analysis
6.4.1. Infectious diseases
6.4.2. Cancer
6.4.3. Others
Chapter 7. Global Vaccine Adjuvants Market, byAdministration
7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Administration, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Administraion2020-2030 (USD Billion)
7.4. Vaccine Adjuvants Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Intradermal
7.4.3. Intranasal
7.4.4. Intramuscular
7.4.5. Others
Chapter 8. Global Vaccine Adjuvants Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Vaccine Adjuvants Market, Regional Market Snapshot
8.4. North America Vaccine Adjuvants Market
8.4.1. U.S.Vaccine Adjuvants Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Administration breakdown estimates & forecasts, 2020-2030
8.4.2. CanadaVaccine Adjuvants Market
8.5. Europe Vaccine Adjuvants Market Snapshot
8.5.1. U.K. Vaccine Adjuvants Market
8.5.2. Germany Vaccine Adjuvants Market
8.5.3. France Vaccine Adjuvants Market
8.5.4. Spain Vaccine Adjuvants Market
8.5.5. Italy Vaccine Adjuvants Market
8.5.6. Rest of EuropeVaccine Adjuvants Market
8.6. Asia-PacificVaccine Adjuvants Market Snapshot
8.6.1. China Vaccine Adjuvants Market
8.6.2. India Vaccine Adjuvants Market
8.6.3. JapanVaccine Adjuvants Market
8.6.4. Australia Vaccine Adjuvants Market
8.6.5. South Korea Vaccine Adjuvants Market
8.6.6. Rest of Asia PacificVaccine Adjuvants Market
8.7. Latin America Vaccine Adjuvants Market Snapshot
8.7.1. Brazil Vaccine Adjuvants Market
8.7.2. MexicoVaccine Adjuvants Market
8.8. Middle East & AfricaVaccine Adjuvants Market
8.8.1. Saudi ArabiaVaccine Adjuvants Market
8.8.2. South AfricaVaccine Adjuvants Market
8.8.3. Rest of Middle East & AfricaVaccine Adjuvants Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. ProductSummary
9.3.1.5. Recent Developments
9.3.2. Novavax, Inc.
9.3.3. Adjuvance Technologies, Inc.
9.3.4. SPI Pharma
9.3.5. Agenus, Inc.
9.3.6. CSL Limited
9.3.7. InvivoGen
9.3.8. AstrazenecaCroda
9.3.9. International Plc
9.3.10. Pfizer Inc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption